José A. Campillo

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism

Blondineth Peláez, José A. Campillo, José A. López‐Asenjo et al. · The Journal of Immunology · 2001 · 90 citations · Full text

Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

Emilio G. de la Concha, J. Bart A. Crusius, José A. Campillo et al. · Journal of Neuroimmunology · 1997 · 77 citations · Full text

Autoimmune Disease, Immunology, Immune Regulation +8

Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population

Ruth López‐Hernández, Mariano Valdés, Daniel Lucas et al. · Human Immunology · 2010 · 50 citations

Genome-wide Association Study, Association Analysis, Disease Susceptibility +12

Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α

Iñigo Angulo, Joaquín Rullás, José A. Campillo et al. · European Journal of Immunology · 2000 · 47 citations · Full text